These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6405547)

  • 61. Propranolol in the treatment of assaultive patients with organic brain disease.
    Greendyke RM; Schuster DB; Wooton JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):282-5. PubMed ID: 6490964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The organic psychosyndrome. Considerations on cerebral blood supply, cerebral metabolism, and therapy (author's transl)].
    Hoyer S
    Nervenarzt; 1978 Apr; 49(4):201-7. PubMed ID: 643135
    [No Abstract]   [Full Text] [Related]  

  • 63. [Acute exogenous psychosis caused by a cerebrovascular accident. Experience with 9 patients].
    Donoso A; Brunetti M; Santander M
    Rev Med Chil; 1984 Oct; 112(10):1017-20. PubMed ID: 6536076
    [No Abstract]   [Full Text] [Related]  

  • 64. [Influence of centrophenoxine on the effect of cyclophosphamide and chloramphenicol in teratological experiment].
    Neumann HJ
    Z Gesamte Inn Med; 1977 Jan; 32(2):59-63. PubMed ID: 322402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The organic brain syndromes.
    Wells CE
    Psychiatr Clin North Am; 1981 Aug; 4(2):319-31. PubMed ID: 7279729
    [No Abstract]   [Full Text] [Related]  

  • 66. [Chronic post-traumatic cerebral psychosyndrome].
    Milosavljević I; Sekulović N; Simonović M; Ignjatović M; Radonjić D; Pavićević R; Lević Z; Durdević M
    Lijec Vjesn; 1973 Jun; 95(6):302-10. PubMed ID: 4727129
    [No Abstract]   [Full Text] [Related]  

  • 67. [Clinical and psychological evaluations of organic brain injury symptoms. A comparative study].
    Jarema M; Kozlowska U
    Psychiatr Pol; 1974; 8(5):495-9. PubMed ID: 4422411
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of centrophenoxin on the sperm motility in mice.
    Sliwa L; Płonka I; Dubis K; Srebro Z
    Folia Biol (Krakow); 1982; 30(1-2):69-74. PubMed ID: 6814962
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of meclofenoxate on learning and memory--dependence on the experimental conditions.
    Mosharrof AH; Yonkov D; Petkov VD; Kambourova T; Todorov I; Alova L
    Acta Physiol Pharmacol Bulg; 1986; 12(3):7-14. PubMed ID: 3101398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Development of psychological EEG research].
    Herzer H; Rabending G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Nov; 35(11):641-7. PubMed ID: 6669646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Comparative evaluation of psychoactive drugs used in patients with subacute and chronic cerebrovascular disorders].
    Wasilewski R; Lebiediewa N; Kozłowa E; Wołkow W
    Neurol Neurochir Pol; 1981; 15(4):447-51. PubMed ID: 6799848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gerontopsychological studies using NAI ('Nürnberger Alters-Inventar') on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative, randomized clinical trial.
    Pék G; Fülöp T; Zs-Nagy I
    Arch Gerontol Geriatr; 1989 Jul; 9(1):17-30. PubMed ID: 2506844
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment results with Cerutil in age-related cerebral insufficiency in general medicine].
    Richter K
    Z Alternsforsch; 1983; 38(1):63-9. PubMed ID: 6405547
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of Cerutil (centrophenoxine) in patients with cerebral sclerosis].
    Schilter R
    Z Alternsforsch; 1974; 28(3):231-8. PubMed ID: 4619249
    [No Abstract]   [Full Text] [Related]  

  • 75. [Cetrexin and its effect on the psychic condition of postprostatectomy patients (author's transl)].
    Bocková E; Polácková J; Toufarová P
    Cas Lek Cesk; 1981 Aug; 120(33):998-1000. PubMed ID: 6794914
    [No Abstract]   [Full Text] [Related]  

  • 76. [Double-blind collaborative study of centrophenoxine versus placebo in patients with neurasthenic syndromes].
    Pieschl D; Angersbach P; Kolbe M; Toman M
    Nervenarzt; 1983 Jan; 54(1):48-53. PubMed ID: 6405290
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.